title: Characterising an aluminium oxide dosimetry system.
abstract: In vivo dosimetry is recommended as a defence-in-depth strategy in radiotherapy treatments and is currently employed by clinics around the world. The characteristics of a new optically stimulated luminescence dosimetry system were investigated for the purpose of replacing an aging thermoluminescence dosimetry system for in vivo dosimetry. The stability of the system was not sufficient to satisfy commissioning requirements and therefore it has not been released into clinical service at this time.
authors.affiliation: William Buckland Radiation Oncology, Alfred Health, Melbourne, Australia. c.conheady@wbrc.org.au.
authors.forename: Clement F
authors.initials: CF
authors.lastname: Conheady
authors.affiliation: William Buckland Radiation Oncology, Alfred Health, Melbourne, Australia.|School of Health Sciences, RMIT University, Melbourne, Australia.
authors.forename: Frank M
authors.initials: FM
authors.lastname: Gagliardi
authors.affiliation: William Buckland Radiation Oncology, Alfred Health, Melbourne, Australia.|School of Health Sciences, RMIT University, Melbourne, Australia.
authors.forename: Trevor
authors.initials: T
authors.lastname: Ackerly
mesh_terms: D000537:Aluminum Oxide / Q000737:chemistry*; D018787:Radiation Oncology; D011874:Radiometry / Q000379:methods*
chemical_list: D000537:Aluminum Oxide
keywords: Aluminium oxide; In vivo dosimetry; OSL; Radiation oncology